exam 5 Flashcards
what is the committed step of purine biosynthesis
PRPP to 5 phospho-B-D-ribosylamine
PRPP glutamyl transferase
amido transferase
how is the committed step of purine biosynthesis regulated
positive = PRPP negative = product inhibion like IMP,GMP, AMP
for the committed step of purine biosynthesis how does alpha of ribosyl get inverted to beta
Mechanism is SN2 so the nucleophine (amino group)must attack at the opposite face of the leaving group resulting in a switch from alpha to Beta
why is ATP not required in committed step of purine biosynthesis
no activated intermediate because we have a good leaving group
drug inhibits adenylate cyclase which makes cAMP
2 groups one with and wihtout drug and both no food for 8 hours who has lower blood glucose
drug treated
drug inhibits adenylate cyclase which makes cAMP
2 groups one with and wihtout drug and both no food for 8 hours upon what organ is the drug accting
liver
drug inhibits adenylate cyclase which makes cAMP
2 groups one with and wihtout drug and both no food for 8 hours
pathway of organ, treatment alteration, downstream effect
inhibits the activation of glycogen breakdown by inhibiting adenylate cyclase
usually when fasting glucagon ->activated g protein to activated adenylate cyclase (drug inhibition here) to increased cAMP to activated pKA which will both phosphorylate phosphoylase kinase to phosphoyrlate phosphoyrlase to activate glycogen break down and phosphorylate glycoge synthase to inactivate it
so the drug blocks the downstream effect of inhibiting glycogen synthase and activating glycogen phosphorylase
HOW DOES THIS REDUCE BLOOD GLUCOSE
role of malate/aspartate shuttle
restores NADplus to the cytosol
is the malate/aspartate shutttle more impoortant for aerobic or anarobic conditions
aerobic conditions because in anaerobic conditions the conversion of pyruvate to lactate maintains NADplus in cytosal for glycolysis to continue
reciperocal regulated
one path is inhibited while other is activated
why RR glycolysis and gluconeogensisis
GLycolysis generates energy but gluconeogenisis requires energy so it would be wasteful to use simultaneously
signal for RR glycolysis and gluconeogenesis
F-2-6-BP activates glycolysis by stimulateing PFK1 activiety to increase conversion of f6P to F16B2
F26BP inhibits gluconeogenisis by negatively regulating F16BP which inhibits the conversion of F16BP to F6P
pyruvate dehydrogenase consists of a highly organized supramolecular complex containgig multiple copies of each of three enYems that are arranged with one type in aninteral cluster with two types in oustide clusters
true
composed of 3 enzymes E1-3
E1 and E3 are outside so they can pick up substrate (pyruvate) and release products(acetylu CoA, CO2 and NADH)
coenzyme co-substrates that are non-covalently attatched to pyruvate dehydrogenase include NAD+ and Coenzyme A
NAD+ = E3 co-enzyme cosubstrate and Coa = E2 co co
TPP for E1 and lipoamide for E2 and FAD for e3 are all prosthetic groups
NADH but not acetyl CoA is a competitive and an allosteric regulator of specific enYmes fo rPDH supramolecular complex
false
acetyl CoA is a negative regulator of PDH